Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPearson Regulatory News (PSON)

Share Price Information for Pearson (PSON)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 948.00
Bid: 945.00
Ask: 945.40
Change: 10.80 (1.15%)
Spread: 0.40 (0.042%)
Open: 937.80
High: 948.20
Low: 935.80
Prev. Close: 937.20
PSON Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disposal

1 Apr 2020 16:23

RNS Number : 4739I
Pearson PLC
01 April 2020
 

Pearson announces completion of sale of remaining 25% stake in Penguin Random House

1st April 2020

 

Pearson, the world's learning company, has today completed the sale of its remaining 25% stake in Penguin Random House for approximately $675m (£530m1) to Bertelsmann SE & Co KGaA ("Bertelsmann"). The transaction was announced on 18th December 2019 and completes Pearson's exit from the venture which, going forward, will be wholly owned by Bertelsmann. 

 

In our announcement in December, we stated our intention to return £350m of net proceeds to our shareholders through a share buyback programme, which we subsequently commenced in early 2020. In our trading update on 23rd March, in light of the rapidly changing environment caused by the COVID-19 pandemic, we further stated that the Board had decided it was prudent to pause the share buyback with approximately £167m of the £350m share repurchase programme completed to date.

 

Pearson has significant financial headroom with approximately £1bn in total liquidity immediately available from cash and our Revolving Credit Facility at the end of February 2020. Given the current circumstances, we are looking at all options to maximise our liquidity and therefore will retain the proceeds from the disposal of our 25% stake in Penguin Random House to further strengthen our short-term financial position.

 

John Fallon, Pearson's chief executive, said: "As our venture with Bertelsmann comes to an end, we wish our colleagues and authors in Penguin Random House every future success. While we are experiencing unprecedented times as a result of COVID-19, we are taking all precautionary measures to protect our business. Our balance sheet is strong, our net debt is relatively low, and we have good liquidity. Furthermore, the growing interest in online learning puts us in a strong position given our global leadership and investment in this area."

 

Notes

1 Based on $/£ exchange rates of 1.27

Contacts

Investor Relations

Jo Russell

Anjali Kotak

07785 451266

07802 890724

Media

Tom Steiner

Gemma Terry

07787 415891

07841 363216

Brunswick

Charles Pretzlik, Nick Cosgrove, Simone Selzer

0207 404 5959

 

Forward looking statements: Except for the historical information contained herein, the matters discussed in this statement include forward-looking statements. In particular, all statements that express forecasts, expectations and projections with respect to future matters, including trends in results of operations, margins, growth rates, overall market trends, the impact of interest or exchange rates, the availability of financing, anticipated cost savings and synergies and the execution of Pearson's strategy, are forward-looking statements. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that will occur in future. They are based on numerous assumptions regarding Pearson's present and future business strategies and the environment in which it will operate in the future. There are a number of factors which could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements, including a number of factors outside Pearson's control. These include international, national and local conditions, as well as competition. They also include other risks detailed from time to time in Pearson's publicly-filed documents and you are advised to read, in particular, the risk factors set out in Pearson's latest annual report and accounts, which can be found on its website (www.pearson.com/corporate/investors.html). Any forward-looking statements speak only as of the date they are made, and Pearson gives no undertaking to update forward-looking statements to reflect any changes in its expectations with regard thereto or any changes to events, conditions or circumstances on which any such statement is based. Readers are cautioned not to place undue reliance on such forward-looking statements.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DISEASLFEAAEEFA
Date   Source Headline
8th Sep 20239:23 amRNSHolding(s) in Company
1st Sep 202310:04 amRNSTotal Voting Rights
29th Aug 20234:06 pmRNSHolding(s) in Company
1st Aug 202310:09 amRNSTotal Voting Rights
31st Jul 20237:00 amRNSPearson 2023 Interim Results
28th Jul 20239:31 amRNSCommittee Changes
27th Jul 20239:48 amRNSDirector Declaration
19th Jul 20234:13 pmRNSDirector/PDMR Shareholding
4th Jul 20239:10 amRNSDirector/PDMR Shareholding
3rd Jul 20233:38 pmRNSTotal Voting Rights
14th Jun 20235:17 pmRNSHolding(s) in Company
1st Jun 202312:32 pmRNSBlock listing Interim Review
1st Jun 202312:28 pmRNSTotal Voting Rights
26th May 20234:48 pmRNSHolding(s) in Company
19th May 20233:00 pmRNSDirector/PDMR Shareholding
17th May 20234:50 pmRNSDirector/PDMR Shareholding
16th May 20234:16 pmRNSDirector/PDMR Shareholding
10th May 20234:30 pmRNSDirector/PDMR Shareholding
10th May 202310:49 amRNSDirectorate Change
9th May 20234:15 pmRNSHolding(s) in Company
9th May 20239:00 amRNSPearson: Generative AI Strategy Update
4th May 20234:30 pmRNSDirector/PDMR Shareholding
4th May 20234:30 pmRNSDirector/PDMR Shareholding
4th May 20234:30 pmRNSDirector/PDMR Shareholding
3rd May 20234:13 pmRNSHolding(s) in Company
2nd May 20233:57 pmRNSTotal Voting Rights
28th Apr 20231:11 pmRNSResult of AGM
28th Apr 20237:00 amRNSPearson 2023 Q1 Trading Update
20th Apr 20234:19 pmRNSHolding(s) in Company
11th Apr 20239:17 amRNSHolding(s) in Company
4th Apr 20234:30 pmRNSDirector/PDMR Shareholding
4th Apr 20234:00 pmRNSHolding(s) in Company
4th Apr 20237:00 amRNSDirector/PDMR Shareholding
3rd Apr 20233:00 pmRNSTotal Voting Rights
31st Mar 20233:44 pmRNSForm 20-F for the year ended 31 December 2022
31st Mar 20232:29 pmRNSHolding(s) in Company
28th Mar 202311:17 amRNSDirector Declaration
27th Mar 20234:05 pmRNSHolding(s) in Company
24th Mar 202312:30 pmRNSNotice of AGM
23rd Mar 20237:00 amRNSPearson Completes Acquisition of PDRI
21st Mar 20237:00 amRNSPearson to sell POLS
16th Mar 20233:09 pmRNSAnnual Financial Report
16th Mar 202311:28 amRNSDirector Declaration
7th Mar 20234:36 pmRNSDirector/PDMR Shareholding
3rd Mar 20237:00 amRNSPearson 2022 Preliminary Results
2nd Mar 20233:37 pmRNSCommittee Change
1st Mar 202310:10 amRNSTotal Voting Rights
8th Feb 20232:37 pmRNSHolding(s) in Company
3rd Feb 20234:23 pmRNSDirector/PDMR Shareholding
1st Feb 202311:10 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.